Literature DB >> 5032032

Carcinoid liver metastases treated with hepatic dearterialization.

S Aune, G Schistad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5032032     DOI： 10.1016/0002-9610(72)90361-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  7 in total

1.  Hepatic artery ligation in treatment of carcinoid syndrome.

Authors:  B I Jugdutt; M Watanabe; F W Turner
Journal:  Can Med Assoc J       Date:  1975-02-08       Impact factor: 8.262

2.  Temporary liver dearterialization in patients with metastatic carcinoid disease.

Authors:  S Bengmark; M Ericsson; A Lunderquist; H Mårtensson; A Nobin; M Sako
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

3.  Angiographic and computed tomographic appearance of secondary carcinoid of the liver.

Authors:  M Sako; A Lunderquist; T Owman; H Mårtensson; A Nobin
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

4.  Metastatic carcinoid to the liver treated by hepatic dearterialization.

Authors:  W V McDermott; T W Hensle
Journal:  Ann Surg       Date:  1974-09       Impact factor: 12.969

5.  Repeated hepatic ischemia as a treatment for carcinoid liver metastases.

Authors:  B G Persson; A Nobin; B Ahrén; B Jeppsson; B Månsson; S Bengmark
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

6.  Dearterialization of the liver for metastatic cancer. Clinical, angiographic and pathologic observations.

Authors:  W V McDermott; A L Paris; M E Clouse; W A Meissner
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

Review 7.  Neuroendocrine metastases of the liver.

Authors:  I Ihse; B Persson; S Tibblin
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.